SURF insider filings

Surface Oncology, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-09-08. Screen SURF transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for SURF between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Surface Oncology, Inc.

FiledFormInsiderReported transactionsSource
2023-09-084FEES JESSICA — Chief Financial OfficerDisposition to issuer (D): 101,915 · Disposition to issuer (D): 150,000 (derivative) @ $0EDGAR
2023-09-084Adams Chandra — Deputy GCDisposition to issuer (D): 23,884 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0EDGAR
2023-09-084RATH HENRY C. — Chief Business OfficerDisposition to issuer (D): 44,971 · Disposition to issuer (D): 150,000 (derivative) @ $0EDGAR
2023-09-084ROSS ROBERT W. — Chief Executive Officer, DirectorDisposition to issuer (D): 83,193 · Disposition to issuer (D): 400,000 (derivative) @ $0EDGAR
2023-09-084GRAYZEL DAVID S. — DirectorDisposition to issuer (D): 2,945,453EDGAR
2023-09-084Sigal Charles Elliott — DirectorDisposition to issuer (D): 45,453 · Disposition to issuer (D): 113,636 (derivative) @ $0EDGAR
2023-09-084Goater Jeff — DirectorDisposition to issuer (D): 129,222EDGAR
2023-09-084Palombella Vito J. — Chief Scientific OfficerDisposition to issuer (D): 87,212 · Disposition to issuer (D): 150,000 (derivative) @ $0EDGAR
2023-09-084ONEILL ALISON — Chief Medical OfficerDisposition to issuer (D): 56,686 · Disposition to issuer (D): 150,000 (derivative) @ $0EDGAR
2023-08-114Adams Chandra — Deputy GCSale (S): 3,901 @ $0.94EDGAR
2023-08-114FEES JESSICA — Chief Financial OfficerSale (S): 9,434 @ $0.94EDGAR
2023-08-114ROSS ROBERT W. — Chief Executive OfficerSale (S): 16,713 @ $0.94EDGAR
2023-08-114ONEILL ALISON — Chief Medical OfficerSale (S): 7,042 @ $0.94EDGAR
2023-03-034RATH HENRY C. — Chief Business OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2023-03-034ROSS ROBERT W. — Chief Executive OfficerGrant/award (A): 400,000 (derivative) @ $0EDGAR
2023-03-034Adams Chandra — Deputy GCGrant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2023-03-034FEES JESSICA — Chief Financial OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2023-03-034Palombella Vito J. — Chief Scientific OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2023-03-034ONEILL ALISON — Chief Medical OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2022-11-034Adams Chandra — Deputy GCGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-08-054RATH HENRY C. — Chief Business OfficerSale (S): 5,676 @ $1.72EDGAR
2022-08-054ROSS ROBERT W. — Chief Executive OfficerSale (S): 10,594 @ $1.72EDGAR
2022-08-054FEES JESSICA — Chief Financial OfficerSale (S): 5,980 @ $1.72EDGAR
2022-08-054Palombella Vito J. — Chief Scientific OfficerSale (S): 4,463 @ $1.72EDGAR
2022-08-054ONEILL ALISON — Chief Medical OfficerSale (S): 4,463 @ $1.72EDGAR
2022-06-304Brunn Carsten — DirectorGrant/award (A): 48,000 (derivative) @ $0EDGAR
2022-06-104Torres Denice — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-06-104Hickey Benjamin — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-06-104Ibrahim Ramy — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-06-104GRAYZEL DAVID S. — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-06-104Sigal Charles Elliott — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-06-104Goater Jeff — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-06-104Shanafelt Armen — Director, 10% ownerGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-06-104Stelzer Laurie — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-04-014Boni Theresa — General Counsel & SecretaryGrant/award (A): 120,000 (derivative) @ $0EDGAR
2022-03-034ROSS ROBERT W. — Chief Executive OfficerGrant/award (A): 56,000 @ $0 · Grant/award (A): 359,000 (derivative) @ $0EDGAR
2022-03-034RATH HENRY C. — Chief Business OfficerGrant/award (A): 38,000 @ $0 · Grant/award (A): 108,000 (derivative) @ $0EDGAR
2022-03-034FEES JESSICA — Chief Financial OfficerGrant/award (A): 38,000 @ $0 · Grant/award (A): 108,000 (derivative) @ $0EDGAR
2022-03-034Palombella Vito J. — Chief Scientific OfficerGrant/award (A): 38,000 @ $0 · Grant/award (A): 108,000 (derivative) @ $0EDGAR
2022-03-034ONEILL ALISON — Chief Medical OfficerGrant/award (A): 38,000 @ $0 · Grant/award (A): 108,000 (derivative) @ $0EDGAR
2022-01-144FEES JESSICA — Chief Financial OfficerSale (S): 19,854 @ $6.10EDGAR
2022-01-144ROSS ROBERT W. — Chief Executive OfficerSale (S): 33,500 @ $6.10EDGAR
2022-01-144Nogelo Liisa I — Chief Legal OfficerSale (S): 26,325 @ $6.10EDGAR
2022-01-144Goater Jeff — DirectorSale (S): 127,778 @ $6.10EDGAR
2022-01-144Palombella Vito J. — Chief Scientific OfficerSale (S): 26,325 @ $6.10EDGAR
2022-01-144ONEILL ALISON — Chief Medical OfficerGrant/award (A): 45,000 @ $0 · Sale (S): 14,809 @ $6.10EDGAR
2022-01-054Hickey Benjamin — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-01-054Torres Denice — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2021-08-034Torres Denice — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2021-06-114Goater Jeff — DirectorOption exercise (M): 200,000 @ $4.14 · Option exercise (M): 34,727 @ $4.14 · Sale (S): 234,727 @ $7.66 · Option exercise (M): 10,273 @ $4.14 · Sale (S): 15,273 @ $7.61 · Option exercise (M): 200,000 (derivative) @ $0 · +2 moreEDGAR

Recent 8-K events — Surface Oncology, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-09-088-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-308-K8.01 — Other EventsEDGAR
2023-08-028-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-07-108-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-07-038-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-168-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-01-128-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=SURF returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs